Updated information and services can be found at: Our previous studies have shown that spontaneously arising immunocytomas in the LOU/Wsl strain of rats contain a t(6;7) chromosomal translocation in all seven tumors studied (F. Wiener, M. Babonits, J. Spira, G. Klein, and H. Bazin, Int. J. Cancer 29: [431][432][433][434][435][436][437] 1982). We have also shown that the c-myc is located on chromosome 7 (J. Sumegi, J. Spira, H. Bazin, J. Szpirer, G. Levan, and G. Klein, Nature (London) 306: [497][498][499] 1983) and the immunoglobulin H cluster on chromosome 6 (W. S. Pear, G. Wahistrom, J. Szpirer, G. Levan, G. Klein, and J. Sumegi, Immunogenetics 23:393-395, 1986). We now report a detailed cytogenetic and molecular analysis of nine additional rat immunocytomas. The t(6;7) chromosomal translocation is found in all tumors. Mapping of the c-myc breakpoints showed that in 10 of 14 tumors, the c-myc breakpoints are clustered in a 1.5-kilobase region upstream of exon 1. In contrast with sporadic Burkitt's lymphoma and mouse plasmacytoma, only 1 of 14 tumors contains the c-myc breakpoints in either exon 1 or intron 1. Analysis of the sequences juxtaposed to the c-myc show that immunoglobulin H switch regions are the targets in at least five tumors and that there is a strong correlation between the secreted immunoglobulin and the c-myc target. Unlike sporadic Burkitt's lymphoma and mouse plasmacytoma, at least two rat immunocytomas show recombination of the c-myc with sequences distinct from immunoglobulin switch regions.
Consistent chromosomal translocations are thought to play an important role in the development of certain neoplasms (10, 21) . The role of specific translocations has been extensively studied in two B-cell tumors, Burkitt's lymphoma (BL) and mouse plasmacytoma (MPC), and chromosomal translocations have been identified in 100% of the former and 95% of the latter type of tumor (22) . BL and MPC represent different stages of B-cell maturation; however, the chromosome translocation in both tumors involves the chromosomes containing one of the immunoglobulin loci and the c-myc cellular oncogene (23) . The translocation is believed to act by constitutive activation of c-myc (9) . Recent facsimile experiments have shown that constitutively activated c-myc genes can induce tumors in an appropriate host environment (1, 24, 27) .
A third tumor in which a chromosomal translocation is consistently associated with B-cell neoplasia is the rat immunocytoma (RIC) (2; H. Bazin, W. S. Pear, and J. Sumegi, in press). The RIC is a plasma cell tumor arising in approximately 30%o of the rats of the LOU/Wsl strain. Approximately 60% of the tumors secrete immunoglobulins, and nearly half of these produce immunoglobulin E (IgE). IgA is produced by less than 5%. This is in contrast with the BALB/c mouse plasmacytoma, in which IgA is secreted in approximately 74% of the tumors and IgE secretion has never been seen (39) . Likewise, IgE is very rarely secreted by human myeloma, in which IgG is the favored isotype (Bazin et al., in press). BL is thought to be an earlier cell in the B-cell lineage and expresses either surface or secretory IgM (9) .
Cytogenetic analysis of seven RICs has shown that they all contain a translocation between chromosomes 6 and 7 (56) . We have localized the rat IgH, K, and A loci to chromosomes 6, 4, and 11, respectively (35, 37 ; Wahlstrom et al., submitted for publication). In addition, we have assigned the c-myc to chromosome 7 and have shown that it is rearranged in four of five analyzed RICs (53) . The chromosome localization and c-myc rearrangement studies suggested that the RIC chromosomal translocation involves the IgH and c-myc loci. A detailed structural analysis of the chromosomal translocation in one tumor, IR75, has shown that this is the case; however, in this tumor c-myc-IgH juxtaposition involved multiple events (34) .
Because the RIC shows significant biological differences from both MPC and BL, a detailed structural study of the t(6;7) translocation is important to distinguish between essential and nonessential features of c-myc activation by chromosomal translocation. Our detailed cytogenetic and structural analysis of 16 RICs showed that the t(6;7) translocation occured in all cases. In 10 of 14 tumors, the c-myc breakpoints clustered in a 1.5-kilobase (kb) region upstream of exon 1, in a region distinct from the usual BL and MPC breakpoints. In contrast to most sporadic BLs and MPCs, only 1 of 14 tumors contained the c-myc breakpoint in either exon 1 or intron 1. One tumor contained the c-myc break- show rearrangement within a 35-kb region surrounding the gene. As with BL and MPC, switch regions are the favored IgH targets in RIC and there is a frequent association between the expressed immunoglobulin and the c-myc target. Unlike sporadic BLs and MPCs, several RICs recombined with sequences outside of IgH switch regions.
MATERIALS AND METHODS
Hybridization probes. The following c-myc probes were used: pMC41-3RC (11), a 1.5-kb ClaI-EcoRI fragment containing exon 3 of human c-myc gene, and pM-Myc54 (50), a 1.1-kb PstI fragment containing part of exon 2 and the entire exon 3 of the mouse c-myc cDNA clone. The following immunoglobulin ,u gene probes were used: pR14 (14), a 3.5-kb Sacl-HindIII fragment containing the rat switch ,u (S,,); pR18 (14), a 1.5-kb BamHI-PstI fragment containing the rat constant ,u (C,,); and M-, (40), a 2.4-kb BamHI-KpnI fragment containing mouse C, ,. The following immunoglobulin 8 probe was used: pb54J (26), a 1-kb mouse cDNA containing C.. The following immunoglobulin yl probes were used: IR75.700 (34) a 700-base-pair (bp) EcoRI-BamHI fragment containing sequences at the 5' border of Syi; Syl (20) , a 2.5-kb EcoRl-HindIII fragment containing the murine S-, region from IgH2; and C,,1 (20) , a 2.4-kb Sacl fragment containing 5'-flanking sequences and coding domains from IgH2. The following -y2 probes were used: y2a (K. B. Marcu, unpublished data), a 4.5-kb EcoRI fragment containing the entire codtng region, pBR1.4 (49), a 1.4-kb EcoRI fragment containing the mouse Sy2b; and Cy2a (43), a 1-kb mouse cDNA containing the 3' end of exon 1 and exons 2 and 3. The following -y3 probe was used: -y3(11) (49), a 6.0-kb BamHI fragment containing the coding region and 3'-flanking sequences from the murine C-y3. The following E probes were used: Se (45), a 1.5-kb HindIII-KpnI fragment derived from murine X clone E-7; IR2:2:11 (19) , a 700-bp PvuII-PstI rat cDNA fragment containing exons 2 to 4; and SD11-E (51), a 3.2-kb EcoRI-HindIII rat genomic fragment containing the region 5' to the e coding domains. The a gene probes were derived from the murine a clone pa64101 (30) and were SOa' a 2.4-kb HindIII-XbaI fragment, and C,L, a 2.0-kb EcoRIXbaI fragment containing exons 1 and 2.
Tumors. All tumors were from the first or second transplant generation which had been subcutaneously inoculated into rats of the LOU/Wsl strain. All cytogenetic and molecular analyses were performed on the tumors.
Karyotypic analysis. Cytogenetic analysis was performed as previously described (56) .
DNA and RNA analysis. DNA and RNA were prepared, electrophoresed, and transferred to Amersham Hybond-N membranes as previously described (34) . Filters were prehybridized as 42°C overnight in a solution containing 6x SSC (lx SSC is 0.15 M NaCl plus 0.015 M sodium citrate), lOx Denhardt solution, 1% sodium dodecyl sulfate (SDS), and 100 ,g of boiled salmon sperm DNA per ml. Hybridization reactions were incubated at 42°C for 18 h in a solution consisting of 6x SSC, 1% SDS, 50% formamide, 5% dextran sulfate, and 100 ,ug of salmon sperm DNA per ml. 32p_ labeled probe (17) was added at a concentration of 106 cpm/ml. The membranes were washed twice at room temperature in 2x SSC-0.1% SDS for 30 min, twice at 65°C in 0.2x SSC-0.1% SDS for 1 h, and 5 min at room temperature in 0.1% SSC. The membranes were exposed to Fuji X-ray film with intensifying screens for 1 to 3 days. The radioactively labeled probe was removed by washing the filters for 10 min twice in a boiling solution of 0.02x SSC-0.1% SDS. Filters were prehybridized immediately after stripping for 4 h and stored at 4°C in prehybridization solution.
Densitometry was performed on a LKB Ultrascan XL laser densitometer by using Gaussian fit analysis.
DNA cloning and nucleotide sequencing. The DNA was digested by restriction endonucleases and size fractionated on sucrose gradients. Fractions of interest were pooled and ligated into appropriate lambda vectors (29) . Libraries were constructed and screened as described (28 The c-myc breakpoints cluster in a 1.5-kb region upstream of exon 1. The rat c-myc gene is located on a 17-kb EcoRI fragment which contains all three exons and 5'-and 3'-,,, _ 4 flanking sequences (34, 52, 53) . Our previous studies have V shown that the c-myc is rearranged in four of five RICs (53). 14 15 To study c-myc rearrangement in the RIC, the breakpoints were mapped in 14 tumors. BamHI digestion divides a 32-kb region surrounding the c-myc into four regions ( fragment should be visible on the autoradiograph. The results of those experiments which best localized the c-myc breakpoints are shown in Table 1 and summarized below. BamHI digestion of 14 RICs and hybridization to the myc.930 probe, which contains P1 and 800 bp of 5'-flanking sequences, showed at least one additional band, in addition to the 930-bp germ line fragment in seven of the tumors (data not shown). To localize the breakpoints within the 930-bp BamHI fragment, advantage was taken of the fact that PvuII divides this region into two fragments of 480 and 450 bp ( (IR72,  IR88 , IR209, and IR223) contained breakpoints within the 480-bp BamHI-PvuII region, whereas three tumors (IR27, IR33, and IR50) contained breakpoints within the 450-bp PvuII-BamHI fragment ( Fig. 2B and 3) . Several of the tumors showed two rearranged bands, indicating the presence of both the c-myc coding and reciprocal products of the translocation (G. Wahlstrom and W. S. Pear, unpublished data). The location of the IR74 breakpoint within the 930-bp BamHI region was not further investigated.
Two tumors, IR75 and IR241, which did not show rearrangement upon BamHI digestion and hybridization with myc.930, showed rearranged bands when cleaved with XbaI and hybridized with myc.930, mycl.1 (Table 1) , and myc.600 (data not shown). This result was consistent with rearrangement occurring within the 600-bp XbaI-BamHI fragment (Fig. 2B3 ). These findings showed that the c-myc rearrangements in 10 Pear, unpublished) . In addition, HindIII digestion and hybridization with mycl.1 also revealed a rearranged fragment (data not shown). Hybridization of the human exon 3 1.5-kb ClaI-EcoRI fragment with the cloned 17-kb rat c-myc-containing EcoRI fragment (34) has shown that the region of homology is located within the 2.3-kb PstI-XhoI fragment (Fig. 2B) . The finding that XbaI digestion and hybridization with the human exon 3 probe showed a 3.1-kb rearranged band indicates that the rearrangement occurs in the vicinity of this region (Fig. 2B) .
BamHI digestion of IR9 and IR304 DNA and hybridization to myc.600, myc.930, mycl.1, and the exon 3 probes showed only germ line fragments (data not shown). Digestion with other enzymes, including XbaI, also failed to show rearrangement with these probes ( (Fig. 2A) . The breakpoints of 4 tumors, IR50, IR75, lR209, and IR223, which have been sequenced are shown. 223r indicates the breakpoint in the reciprocal product of the 1R223 translocation. The proximal promoter is also shown. The proximal promoter has been positioned by homology to the human and mouse sequences (Steffen and Nacar, submitted). All nucleotides which are homologous between rat, mouse (4, 8) , and human (46) are underlined. The region which is homologous to DNase I hypersensitivity site lIII is boxed. The method of comparison is described in the text.
Sequencing of the 1.5-kb region containing the c-myc breaktomas (58) and is also the site of proviral insertion in murine point cluster reveals several regions of homology between the T-cell lymphomas (7, 25, 44, 57) and in Moloney-virusrat, mouse, and human sequences. The breakpoint localizainduced rat thymomas (52) . In addition, c-myc regulatory tion studies showed that c-myc rearrangement in 10 of 14 elements have been proposed to reside in this region (3, 6, RICs occurred within a 1.5-kb XbaI-EcoRI fragment, which 41, 46, 58) . To identify conserved regions in the human, contains the proximal promoter and 5'-flanking sequences.
mouse, and rat sequences within the RIC breakpoint cluster
The murine homolog of this region has been shown to be the region, approximately 1.3 kb of this region was sequenced site of c-myc rearrangement in a subset of mouse plasmacy- (Fig. 4) . The homology between the rat, mouse, and human sequences was determined as follows. The rat and mouse sequences (4, 8) were aligned to maximize homology, with gaps introduced to improve the alignment (31) . A consensus sequence was derived from this alignment (13) . The rat and human (46) sequences were similarly aligned, and a consensus sequence was created. Figure 4 shows the regions of homology when the consensus sequences are aligned with the rat sequence. The overall homology between the rat and mouse sequences is 74%, whereas the homology between rat and human sequences is 69%. In comparison, the homology between mouse and human sequences is approximately 70% (8) . Several regions show particularly high homology, including the regions around the promoters (Fig. 4 ; Steffen and Nacar, submitted) which contain DNase I hypersensitivity sites III1 and 1112 (16, 46) . There is low homology around DNase I hypersensitivity site 1I2 (46) and the PO promoter (3). These regions have also been shown to lack sequence homology between mouse and human sequences (3, 8) ; however, Fahrlander et al. (16) have shown that there is a region in the murine c-myc which shows a DNase hypersensitivity pattern similar to that of DNase I hypersensitivity site II2.
The t(6;7) translocation frequently juxtaposes the c-myc with IgH-constant regions. Our study of the IR75 in which the c-myc was juxtaposed to the switch ,. region (34) suggested that recombination of the c-myc with the IgH-constant region may be a frequent result of the RIC t(6;7) translocation. To investigate if immunoglobulin-constant regions were involved in other tumors, genomic comigration experiments were performed on those tumors which showed c-myc rearrangement. This was done by rehybridizing the blots which showed c-myc rearrangement with immunoglobulinconstant and switch region probes (see Materials and Methods). The results are summarized in Table 1 .
When hybridized with an E cDNA probe (19) , EcoRIBamHI double digestion of rat liver DNA shows a 7.5-kb band which contains the four coding domains, switch E sequences, and 3'-flanking sequences (5) . Figure SA In addition, BamHI digestion of IR223 identified a 2.4-kb fragment which hybridized to both of these probes (data not shown). To localize the breakpoints in the E region, DNA from IR50, IR72, IR74, IR88, and IR223 was digested with KpnI and hybridized to the E cDNA probe. KpnI cleaves upstream of exon 1, and hybridization experiments with the mouse switch £ probe (45) show that the switch E region lies upstream of the KpnI site (see Fig. 6C ) (W. S. Pear, unpublished data). Of the five tumors which showed comigration between the c-myc and F, only the IR223 showed a rearranged fragment after hybridization to the E cDNA probe (Pear et al., submitted) . This fragment also appeared as a rearranged band when this filter was rehybridized with myc.930 (data not shown). These experiments show that four of the five tumors which rearrange with the E rearrange with sequences upstream of the coding domains and most likely in the E switch region. The IR223, on the other hand, rearranges with a region which is distinct from the switch e (Pear et al., submitted) .
Of the five tumors in which the c-myc is juxtaposed with the E locus, three tumors (IR50, IR72, and IR88; Table 1 ) are E producers. The IR74 does not produce myeloma proteins, and Northern (RNA) blots do not detect E expression (Pear, unpublished) . The IR223 produces Bence-Jones proteins; however, an abnormally sized E transcript is detected by Northern hybridization (Pear et al., submitted) .
Digestion of DNA from the -yl producer, IR241, with XbaI, hybridization with a murine -yl-constant region probe (20) , and rehybridization with myc.930 showed that the 18-kb rearranged fragment hybridized to both probes. In addition, Hindlll digestion of IR241 DNA and hybridization of a probe which originates from the 5' portion of the switch yl region (34) showed that a 23-kb rearranged fragment MOL. CELL. BIOL. (Fig. 4) .
Homology is indicated by a vertical line. V, Chromosome 7 breakpoint; *, characteristic switch E repeats (32).
hybridized to both probes. We have been unable to localize the exact breakpoint within the -y region because the rat -yconstant and switch region probes cross-hybridize with each other, even at high stringency conditions (5, 34; Pear, unpublished) . None of the other five tumors showed comigration between the rearranged c-myc and IgH switch or constant region probes. Cloning of the rearranged c-myc fragment from several tumors shows that the c-myc and IgH regions are juxtaposed head to head; however, rearrangement is not always with an IgH switch region, and one tumor juxtaposes the c-myc with repetitive DNA. To verify the breakpoint and comigration results, the rearranged c-myc BamHI fragments were cloned from the c-producing IR50 and the Bence-Jones proteinsecreting IR223, and the rearranged c-myc EcoRI fragment was cloned from the y2a-producing IR209. The sizes of the cloned rearranged fragments corresponded to our genomic results. The map of the rearranged 4.8-kb c-myc fragments from the IR50 is shown in Fig. 6B . Hybridization of myc.930 and a murine switch E probe (45) to the 5-kb IR50 clone showed that both probes hybridized to the 1.5-kb SaclBamHI fragment (Fig. 6B) . Sequencing of part of this region showed that the c-myc breakpoint occurred 108 bp upstream of the proximal promoter within the predicted 450-bp PvuIIBamHI fragment (Fig. 6D) . Juxtaposed to the c-myc are sequences originating from the switch c region (Fig. 6D ) This has been verified by hybridizing the breakpoint-containing BamHI-SacI fragment to Sacl-digested LOU/Ws1 liver DNA. Only the c-myc germ line 2.1-kb band and the 4.1-kb switch e-specific bands were present (data not shown). Mapping and sequencing of the 2.4-kb rearranged c-myc fragment from the IR223, as well as a 9.6-kb fragment which contains the reciprocal product of the translocation, showed that the c-myc breakpoint occurred in the predicted 480-bp Northern analysis of RICs (IR numbers appear at top). RNA was prepared from fresh tumors and transferred to nylon membranes as described in Materials and Methods. Hybridization and washing were performed as described in Materials and Methods. Hybridization probes were a 1.6-kb rat BgII fragment containing all of exon 1, approximately 800 bp of 5'-flanking sequences, and 100 bp of intron 1 (Fig.  2B) (A) ; and a 1.1-kb PstI fragment containing the exon 3 of the murine c-myc (50) (B). The bands just below the 18S size marker are from hybridization to the 500-bp XbaI-HindIII fragment containing the rat human glyceraldehyde-3-phosphate dehydrogenase gene (55) . This was done to control for the amount of input RNA. Separate experiments show that there is no comigration between the c-myc transcripts and the GAPDH transcripts (data not shown). Densitometry was performed as described in Materials and Methods.
BamHI-PvuII fragment (Pear et al., submitted). As suggested by the genomic experiments, the £ breakpoint does not occur within the switch e region, but within intron 1 (Pear et al., submitted) . In both the IR50 and IR223, the c-myc and e regions are orientated head to head.
Cloning of the 12-kb rearranged c-myc-containing EcoRI fragment from the IR209 showed that the c-myc breakpoint occurred within the 480-bp BamHI-PvuII fragment (Pear et al., submitted) . The IR209 was a tumor in which the rearranged c-myc fragment did not comigrate with any of the IgH switch or constant region probes. Mapping and sequencing of the c-myc-juxtaposed DNA in this clone and an overlapping BamHI clone failed to identify unique IgH-derived DNA in at least a 7.1-kb region adjacent to the c-myc breakpoint (Pear et al., submitted) . Instead, the juxtaposed sequences originate from a member of a family of middle repetitive elements (Pear et al., submitted), termed LINEs (47), of which 40,000 copies exist in the rat genome (12) . c-myc expression is elevated in the RIC. To assess c-myc expression in the RIC, total RNA was prepared from eight RICs which contain different c-myc breakpoints. All RICs except the IR49 expressed a normal-sized 2.4-kb message (Fig. 7B ). The IR49, in which the translocation removes the normal promoters and first exon, expresses a smaller c-mycspecific message (Fig. 7B) . In comparing those tumors which contain a c-myc breakpoint in the 1.5-kb breakpoint region ( Fig. 7B; IR50, IR75 , IR209, IR223) with IR304, in which the c-myc breakpoint occurs outside of a 35-kb region surrounding the gene, there is no significant difference in the level of c-myc expression (Fig. 7B ). The IR221, in which the c-myc breakpoint occurs in the vicinity of the third exon, shows a sevenfold-lower level of transcription, and the IR49, in which the translocation decapitates the first exon, shows a fivefold-lower level of transcription (Fig. 7B) . The levels of c-myc transcription do not appear to be significantly influenced by the nature of the juxtaposed sequences. The levels of c-myc expression are similar in IR50, IR75, IR209, and IR223, although the c-myc recombines with different regions in each of these tumors (Fig. 7B) .
In both BL and MPC, transcription from the normal c-myc allele either is shut off or occurs at a very low level in comparison with the translocated allele (9) . To study this phenomenon, it is necessary to differentiate between the translocated and nontranslocated c-myc alleles. Of the group of tumors in our study, the only tumor which is amenable to this analysis is the IR49, in which the first exon is decapitated. Hybridization of a c-myc third exon probe to IR49 RNA showed a 2.0-kb transcript (Fig. 7B ). Hybridization with a first exon probe failed to detect a hybridizing signal in the IR49 lane (Fig. 7A) . On the other hand, six other RICs showed a normal-sized 2.4-kb message with this probe (Fig.  7A ). These findings suggest that c-myc transcription in the IR49 emanates from the translocated c-myc allele.
DISCUSSION Of 16
RICs studied, all contain a t(6;7) translocation. This is in contrast to approximately 20% of the BLs and 10% of MPCs in which the translocation involves the chromosomes containing the c-myc and one of the immunoglobulin lightchain loci (9) . Our inability to detect variant translocations in the RIC may be a consequence of the biology of this tumor, or alternatively, our sample size of 16 tumors may be too small to detect an infrequent event.
Comigration studies showed that at least seven RICs juxtapose the c-myc with IgH sequences. Thus, three B-cell tumors (RIC, MPC, and BL) arising in three different species (rat, mouse, and human) by apparently different etiologies contain consistent chromosomal translocations which juxtapose the c-myc and IgH loci. In accordance with the mouse and human studies, the effect of the translocation appears to be activation of the c-myc locus, and as we have documented with one tumor, c-myc expression emanates from the allele involved in the translocation. The regularity of c-myc activation by chromosomal translocation in RIC, MPC, and BL suggests that this is one of the rate-limiting steps in the generation of these tumors. This hypothesis is supported by several studies (1, 27) which show that an activated c-myc gene contributes to B-cell tumorigenesis. These studies suggest, however, that events in addition to c-myc activation are required in the tumorigenic process.
The majority of RICs are IgE producers, in contrast with MPCs and BLs, which usually produce IgA and IgM, respectively (Bazin et al., in press ). The comigration results show that of four tumors which secrete r, three juxtapose the c-myc with switch e sequences. IgH switch regions were the recombination targets inside the IgH gene cluster in all BALB/c and NZB MPCs studied, with switch a as the preferred site in more than 80% of the BALB/c tumors (9) . Switch regions, with switch ,u predominating, are also the favored targets in sporadic BLs (36) . Endemic BLs, on the other hand, often involve recombination of the c-myc with sequences upstream of the switch ,u (18 ally related to a specific class switch or was due to the location of the a and ,u regions. The finding that £ producers show recombination between the c-myc and switch e region suggests that there is an apparent relationship between isotypic expression and the c-myc translocation target. A study of the IgE-secreting IR162 also showed that the c-myc recombines with the switch £ region (54) ; however, as demonstrated by our study of the IgE-producing IR75 (34) , not all IgE-secreting RICs show juxtaposition between the c-myc and switch £.
Although switch regions are the favored c-myc recombination target, it is difficult to distinguish between the possibilities that switch recombinase enzymes are involved in the translocation event and that switch regions are particularly sensitive sites for recombination. Although it does not solve this dilemma, our sequencing of the c-myc breakpoints in two tumors, IR209 and IR223, which do not recombine with switch regions show that the e intron 1 and LINE region sequences which recombine with the c-myc resemble switch regions (Pear et al., submitted). As a result, immunoglobulin switch regions appear to play an important role in mediating the translocation event.
Cloning of the rearranged c-myc genes from three tumors, IR50, IR75, and IR223, has shown that the c-myc and IgH sequences are rearranged head to head. These results are similar to the findings with BL and MPC (9) . This consistent geometry may reflect the chromosomal orientation of the participating genes, or alternatively, this configuration may have functional consequences.
Of 12 RICs which show rearrangement within a 35-kb region surrounding the c-myc, 10 tumors contain c-myc breakpoints within a 1.5-kb XbaI-BamHI region which contains P1 and 5'-flanking sequences. This region is distinct from the site of c-myc rearrangement in the majority of MPCs and sporadic BLs, which occurs in the first exon or 5' portion of intron 1 (9) . The difference in breakpoint cluster regions is unlikely to be due to differences in primary c-myc structure, since the rat and murine c-myc genes are greater than 90% homologous over the region containing exon 1 and the 5' portion of intron 1 (Steffen and Nacar, submitted). In addition, sequencing of 1.2 kb of the 5'-flanking region did not reveal any obvious differences between rat, mouse, and human sequences which could account for the majority of RIC c-myc breakpoints occurring in this region. The difference is also unlikely to be the result of the nature of the sequences juxtaposed to the c-myc, since the E and -y regions lie between the ,. and a regions, which are the favored recombination targets in BL and MPC, respectively. In addition, the finding that the IR49 c-myc breakpoint occurs in intron 1 shows that cryptic promoters can be activated in the RIC translocation.
Although RIC, MPC, and BL show differences in the location of the c-myc breakpoint, the c-myc coding exons 2 and 3 are never interrupted. The finding that the RIC breakpoints cluster in a region distinct from MPC and BL may be related to the nature of the factors promoting the chromosome breakage, fragile sites in the chromosome, or the way in which the c-myc is activated. Several groups (15, 38, 58) have shown that differences in the c-myc breakpoint within the aforementioned region can affect promoter utilization and half-life. These changes, unlike those in which the c-myc is constitutively activated, have not yet been linked to transformation. It has recently been proposed that point mutations in c-myc exon 1, which relieve a block to transcriptional elongation, may be involved in c-myc activation in endemic BLs (36; E. Cesarman, D. Bentley, R. DallaFavera, and M. Groudine, Science, in press). Because the c-myc breakpoints in 13 of 14 RICs do not affect the integrity of the first exon, we cannot rule out that a similar change is occurring in these tumors.
Despite variance in both the locations of the c-myc breakpoint and the nature of the juxtaposed sequences, all analyzed RICs, MPCs, and BLs contain an activated c-myc gene. c-myc activation may be a combination of two events, one being removal of c-myc regulatory sequences either by deletion (9) or point mutation (36; Cesarman et al., in press) and the other being addition of sequences which can activate in cis, i.e., the IgH enhancer, undescribed enhancerlike elements within the immunoglobulin cluster, or possibly activating elements located at other positions in the genome, including active chromatin domains. Although the exact mechanism of c-myc activation may vary between different tumors, its occurrence appears to be essential in the tumorigenic pathway of RIC, MPC, and BL.
